跳至主要内容
临床试验/NL-OMON20780
NL-OMON20780招募中不适用

ow molecular weight heparin (FRagmin (R)) in pregnant women with a history of Uteroplacental Insufficiency and Thrombophilia, a randomized trial (FRUIT-study).

A single grant in the period 2000-2001 of Pharmacia and Upjohn.0 个研究点目标入组 154 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
154

研究概览

简要总结

This is the first trial with low molecular weight heparin in a population of women with a history of preeclampsia and will be submitted to an international journal.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with a history of preeclampsia and/or small for gestaitonal age infants before 34 weeks gestation and documented thrombophilia restricted to proteine c and proteine S deficiency, APC resistance, Factor V Leiden mutation, FActor II mutation, anticardiolipin antibodies, lupus anticoagulant;
  • 2. Age > 18 years;

排除标准

  • 1. Antithrombine deficiency;
  • 2. Diabetes mullitus;

研究者

发起方
A single grant in the period 2000-2001 of Pharmacia and Upjohn.

相似试验